factually
Index/Topics/GLP-1 receptor agonists cardiovascular benefits

GLP-1 receptor agonists cardiovascular benefits

GLP-1 receptor agonists improve multiple cardiovascular risk markers and reduce major adverse cardiovascular events (MACE) while patients are taking them

Fact-Checks

1 result
Jan 12, 2026
Most Viewed

How do GLP‑1 drugs affect cardiovascular risk markers while on treatment versus after discontinuation?

GLP‑1 receptor agonists improve multiple cardiovascular risk markers—weight, glycaemic control, blood pressure, lipids and inflammatory biomarkers—and reduce major adverse cardiovascular events (MACE)...